Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Key Market Feature
1.4 Market Outline
1.5 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 opportunities
4.4 constraints
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Product
6.1 Fecal Occult Blood Tests
6.1.1 Guaiac FOB Stool Test
6.2.2 Immuno-FOB Agglutination Test
6.2.3 Lateral Flow Immuno-FOB Test
6.2.4 Immuno-FOB ELISA Test
6.2 Stool Biomarkers Tests
6.2.1 Cologuard
6.2.2 M2-PK Stool Test
6.3 Blood Biomarkers Tests
6.3.1 ColoSentry
6.3.2 ColoVantage
6.3.3 Epi proColon
6.3.4 mS9
6.4 Biomarker test
6.4.1 Tumor M2-PK stool test
6.4.2 Transferrin assays
6.5 CRC DNA screening test
6.5.1 Methylated gene test
6.5.2 Panel DNA test
Chapter 7 Market Segmentation by Pipeline
7.1 MarCarePlex
7.2 Cologic
7.3 Colox
7.4 miRSIGN
7.5 PanC-Dx
7.6 MeScore CRC
Chapter 8 Market Segmentation by Geography
8.1 Asia Pacific
8.1.1 Introduction
8.1.2 China
8.1.3 India
8.1.4 Japan
8.1.5 Australia
8.1.6 Others
8.2 North America
8.2.1 Introduction
8.2.2 United States
8.2.3 Canada
8.2.4 Mexico
8.2.5 Others
8.3 Europe
8.3.1 Introduction
8.3.2 Spain
8.3.3 UK
8.3.4 France
8.3.5 Russia
8.3.6 Italy
8.3.7 Others
8.4 The Middle East and Africa
8.4.1 Introduction
8.4.2 South Africa
8.4.3 Middle East Countries
8.4.4 Others
8.5 South America
8.5.1 Introduction
8.5.2 Argentina
8.5.3 Brazil
8.5.5 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company profiles
10.1 Analogic Corporation
10.1.1 Business Overview
10.1.2 Product portfolio
10.1.3 Key Strategy
10.1.4 Recent Developments
10.2 R-Biopharm
10.3 Sysmex Corporation
10.4 Abbott Molecular Inc
10.5 Kyowa Medex
10.6 Merck Millipore
10.7 Epigenomics AG
10.8 Abbott Molecular Inc
10.9 Companion Dx
10.10 Randox Laboratories
10.11 Immunostics Co
10.12 MODE Diagnostics Ltd
10.13 Siemens Healthineers
10.14 DanDrit Biotech
10.15 VolitionRX
Chapter 11 Market Estimates and Forecasts
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Product 2018-2024 (USD Million)
11.1.2 Market Estimation and Forecast by Pipeline 2018-2024 (USD Million)
11.1.3 Market Estimation and Forecast by Geography 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
